11C-flumazenil PET in neocortical epilepsy

Area of Science:

• Neuroscience
• Radiology
• Epilepsy Research

Background:

• Extratemporal partial seizures can be challenging to diagnose, especially when high-resolution MRI appears normal.
• Identifying focal cortical abnormalities is crucial for understanding seizure origins and guiding treatment.
• Gamma-aminobutyric acid type A-central benzodiazepine receptors (GABA(A)-cBZRs) play a key role in neuronal inhibition.

Purpose of the Study:

• To investigate focal cortical abnormalities of GABA(A)-cBZRs in patients with extratemporal partial seizures.
• To compare receptor abnormalities in patients with acquired lesions versus those with normal MRI.
• To assess the utility of 11C-flumazenil (FMZ) PET in detecting these abnormalities.

Main Methods:

• Utilized 11C-flumazenil (FMZ) Positron Emission Tomography (PET) to image GABA(A)-cBZRs density (FMZ volume of distribution - FMZVD).
• Studied six patients with acquired lesions and 18 with normal MRI, alongside 24 healthy controls.
• Analyzed PET images using Statistical Parametric Mapping (SPM) for voxel-by-voxel comparisons.

Main Results:

• All patients with acquired lesions showed reduced FMZVD in a single cortical region.
• Thirteen of 18 patients with normal MRI exhibited abnormal cortical FMZVD, including increased, decreased, or both.
• Abnormalities were often localized to the lobe or hemisphere presumed to be the seizure origin.

Conclusions:

• FMZ PET combined with SPM provides an automated, objective, sensitive, and specific method for detecting GABA(A)-cBZR abnormalities in partial seizures.
• This imaging technique is particularly valuable for evaluating patients with normal MRI, aiding in surgical treatment decisions for refractory epilepsy.